In Vitro Synergistic Activity of Rifampicin Combined with Minimal Effective Antibiotic Concentration (MEAC) of Polymyxin B Against Extensively Drug-Resistant, Carbapenem-, and Polymyxin B-Resistant Klebsiella pneumoniae Clinical Isolates
Current Microbiology · 2024
DOI: 10.1007/s00284-024-03897-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2024. Verfasst von Nathália Abichabki und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences of Ribeirão Preto (FCFRP), University of São Paulo (USP), Av. Prof. Dr. Zeferino Vaz - Vila Monte Alegre, Ribeirão …. Hauptthemen laut MEDLINE: Polymyxin B, Rifampin, Klebsiella pneumoniae, Microbial Sensitivity Tests. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Instituto Nacional de Pesquisas em Resistência a Antimicrobianos, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
We investigated the in vitro antibacterial activity of the combination rifampicin (RIF) + polymyxin B (PB) against extensively drug-resistant (XDR) Klebsiella pneumoniae isolates. We evaluated clinical isolates co-resistant to PB (non-mcr carriers; eptB, mgrB, pmr operon, and ramA mutations) and to carbapenems (KPC, CTX-M, and SHV producers; including KPC + NDM co-producer), belonging to sequence types (ST) ST16, ST11, ST258, ST340, and ST437. We used the standard broth microdilution method to determine RIF and PB minimum inhibitory concentration (MIC) and the checkerboard assay to evaluate the fractional inhibitory concentration index (FICI) of RIF + PB as well as to investigate the lowest concentrations of RIF and PB that combined (RIF + PB) had antibacterial activity. Time-kill assays were performed to evaluate the synergistic effect of the combination against selected isolates. PB MIC (32-256 µg/mL) and RIF MIC (32-1024 µg/mL) were determined. FICI (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences of Ribeirão Preto (FCFRP), University of São Paulo (USP), Av. Prof. Dr. Zeferino Vaz - Vila Monte Alegre, Ribeirão Preto, SP, 14040-903, Brazil.
- Ribeirão Preto Medical School (FMRP), University of São Paulo (USP), Av. Bandeirantes, 3900, Campus da USP - Cidade Universitária, Ribeirão Preto, SP, 14040-900, Brazil.
- University Hospital of Ribeirão Preto Medical School (HCFMRP), University of São Paulo (USP), R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto, SP, 14015-010, Brazil.
- Department of Clinical Analyses, Toxicology and Food Science (DACTB), School of Pharmaceutical Sciences of Ribeirão Preto (FCFRP), University of São Paulo (USP), Av. Prof. Dr. Zeferino Vaz - Vila Monte Alegre, Ribeirão…
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Instituto Nacional de Pesquisas em Resistência a Antimicrobianos
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Abichabki, N., Gaspar, G. G., Zacharias, L. V., Pocente, R. H. C., Lima, D. A. F. S., de Freitas, N. A. B., Brancini, G. T. P., Moreira, N. C., Braga, G. Ú. L., Bellissimo-Rodrigues, F., Bollela, V. R., Darini, A. L. C., & Andrade, L. N. (2024). In Vitro Synergistic Activity of Rifampicin Combined with Minimal Effective Antibiotic Concentration (MEAC) of Polymyxin B Against Extensively Drug-Resistant, Carbapenem-, and Polymyxin B-Resistant Klebsiella pneumoniae Clinical Isolates. Current Microbiology. https://doi.org/10.1007/s00284-024-03897-1
Vancouver
Abichabki N, Gaspar GG, Zacharias LV, Pocente RHC, Lima DAFS, de Freitas NAB, et al. In Vitro Synergistic Activity of Rifampicin Combined with Minimal Effective Antibiotic Concentration (MEAC) of Polymyxin B Against Extensively Drug-Resistant, Carbapenem-, and Polymyxin B-Resistant Klebsiella pneumoniae Clinical Isolates. Current Microbiology. 2024. doi:10.1007/s00284-024-03897-1
BibTeX
@article{Abichabki2024,
author = {Abichabki, Nathália and Gaspar, Gilberto Gambero and Zacharias, Luísa Vieira and Pocente, Renata Helena Cândido and Lima, Denissani Aparecida Ferrari Santos and de Freitas, Natália Augusta Barbosa and Brancini, Guilherme Thomaz Pereira and Moreira, Natália Columbaro and Braga, Gilberto Úbida Leite and Bellissimo-Rodrigues, Fernando and Bollela, Valdes Roberto and Darini, Ana Lúcia Costa and Andrade, Leonardo Neves},
title = {In Vitro Synergistic Activity of Rifampicin Combined with Minimal Effective Antibiotic Concentration (MEAC) of Polymyxin B Against Extensively Drug-Resistant, Carbapenem-, and Polymyxin B-Resistant Klebsiella pneumoniae Clinical Isolates},
journal = {Current Microbiology},
year = {2024},
doi = {10.1007/s00284-024-03897-1}
}
EUVIMED